Neuroleptic malignant syndrome due to three atypical antipsychotics in a child

ArticleinJournal of Psychopharmacology 19(4):422-5 · August 2005with7 Reads
Impact Factor: 3.59 · DOI: 10.1177/0269881105053310 · Source: PubMed

    Abstract

    Neuroleptic Malignant Syndrome (NMS) is a rare, potentially fatal and idiosyncratic drug reaction. It is characterized by a sudden loss of body temperature control, renal and respiratory failure, muscle rigidity, loss of consciousness and impairment of autonomic nervous system. Although NMS was previously associated with the use of classical high-potency neuroleptics, cases have started to emerge with atypical neuroleptics. This article discusses the first case of NMS in a child, induced by the use of risperidone, olanzapine and quetiapine.